Projected Cost Savings Associated With Recombinant Tissue Plasminogen Activator Thrombolysis After Acute Ischemic Stroke From The Mexican Public Health Care System Perspective
Abstract
Authors
D.P. Cardona X. Burbano-Levy E. Palacios F. Diez-Canseco S. Herran L. Zapata